Angel Remedies Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Angel Remedies Pharmaceutical Export Portfolio Dataset — 2 Products, $217.6K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Angel Remedies — Pharmaceutical Exporter Profile (2026) | 2 Products, $217.6K Trade | TransData Nexus

Angel Remedies

Indian Pharmaceutical Exporter · Analgesics & Antipyretics Specialist · $217.6K Total Trade · DGFT Verified

Angel Remedies is an Indian pharmaceutical exporter with a total trade value of $217.6K across 2 products in 2 therapeutic categories. Based on 26 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Indomethacin ($187.7K), Paracetamol Caffeine ($29.9K), .

Angel Remedies — Export Portfolio & Destination Treemap

Angel Remedies pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Angel Remedies? — Company Overview & Market Position

Angel Remedies is an Indian pharmaceutical company specializing in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 2009, the company is headquartered in Ahmedabad, Gujarat, India. The registered office is located at 446-447 Sun Gravitas, Near Shyam Prasad Overbridge, Shyamal Cross Road, Satellite, Ahmedabad, Gujarat - 380015.

The company operates as a private limited entity, with a Corporate Identification Number (CIN) of U24232MP1991PTC006344. It was incorporated on April 4, 1991, under the Registrar of Companies, Gwalior. The authorized capital is ₹3.5 million, with a paid-up capital of ₹3.5 million.

Angel Remedies focuses on providing affordable healthcare solutions without compromising on quality. With over 25 years of experience in the pharmaceutical industry, the company is committed to supplying high-quality generic medicines that cater to a broad spectrum of diseases and conditions. This dedication has established Angel Remedies as a trusted name in the industry.

What Does Angel Remedies Export? — Product Portfolio Analysis

Top Products by Export Value

1Indomethacin$187.7K

Product Portfolio — Top 2 by Export Value

Angel Remedies exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Indomethacin	Analgesics & Antipyretics	$187.7K	20	2.0%	8
2	Paracetamol Caffeine	Combination Drugs	$29.9K	6	2.2%	8

Angel Remedies exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $217.6K. The top category is Analgesics & Antipyretics (86.3% of portfolio), followed by Combination Drugs (13.7%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Angel Remedies — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Angel Remedies operates manufacturing facilities in India, specializing in the production of finished pharmaceutical formulations such as tablets, capsules, syrups, and injections. The company emphasizes maintaining high-quality standards in its manufacturing processes to ensure the efficacy and safety of its products. Specific details regarding the locations and capacities of these facilities are not publicly disclosed.

3Key Leadership

The leadership team at Angel Remedies includes:

Maulish Shah: Chief Executive Officer (CEO)
Bansi Radadiya: Head of Operations
Jhanvi Patel: Regulatory Affairs Officer
Rahul Satapara: Business Development Executive
Jainee Shah: Regulatory Affairs Officer

These executives play pivotal roles in steering the company's strategic direction and ensuring operational excellence.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Angel Remedies Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Angel Remedies has established a presence in various regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company exports finished pharmaceutical formulations, such as Indomethacin and Paracetamol Caffeine, to these regions. In 2022, Angel Remedies reported a total export value of $218,000 USD across 26 shipments, with Indomethacin accounting for $188,000 USD and Paracetamol Caffeine for $30,000 USD. These products fall under the therapeutic categories of Analgesics & Antipyretics and Combination Drugs, respectively. The company's portfolio is highly concentrated, with the top five products comprising 100% of the export value.

2Emerging Markets

Angel Remedies has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company's commitment to providing affordable healthcare solutions has facilitated its entry into these regions, where there is a growing demand for quality generic medicines. While specific details regarding WHO prequalification are not publicly available, the company's adherence to international quality standards positions it favorably for market access in these regions.

3Geographic Strategy

Angel Remedies — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Angel Remedies' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's export activities to the United States suggest compliance with FDA regulations; however, without publicly accessible records, a comprehensive assessment of its FDA status cannot be conducted.

2WHO & EU GMP

Angel Remedies' adherence to Good Manufacturing Practices (GMP) is indicated by its manufacturing of finished pharmaceutical formulations. While specific certifications such as WHO prequalification and EU GMP certificates are not publicly disclosed, the company's commitment to quality suggests compliance with international standards. However, without publicly accessible records, a comprehensive assessment of its WHO and EU GMP status cannot be conducted.

3CDSCO & Indian Regulatory

Angel Remedies operates under the regulatory framework of the Central Drugs Standard Control Organisation (CDSCO) in India. The company's manufacturing licenses and approvals from state drug controllers are not publicly disclosed. The export of finished pharmaceutical formulations indicates compliance with Indian regulatory requirements; however, without publicly accessible records, a comprehensive assessment of its CDSCO and Indian regulatory status cannot be conducted.

Angel Remedies — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the pharmaceutical export sector, Angel Remedies faces competition from both large multinational corporations and other Indian pharmaceutical companies. While specific competitors in overlapping therapeutic categories are not publicly disclosed, the company's focus on affordable healthcare solutions positions it in competition with entities that offer similar products in international markets. The high concentration of export value in the top five products indicates a niche focus, which may limit direct competition but also exposes the company to risks associated with market fluctuations affecting these specific products.

2Key Differentiators

Angel Remedies' key differentiators include its commitment to providing affordable healthcare solutions without compromising on quality and its extensive experience in the pharmaceutical industry. The company's focus on high-quality generic medicines that cater to a broad spectrum of diseases and conditions has established it as a trusted name in the industry.

3Strategic Position

Angel Remedies' current strategic direction focuses on exporting a limited range of high-quality generic pharmaceutical formulations to a diverse set of international markets. This approach allows the company to leverage its manufacturing capabilities and meet the needs of various global markets. The future outlook appears to involve expanding its product portfolio and enhancing its presence in emerging markets, aligning with the company's mission to improve the quality of health worldwide.

Buyer Due Diligence Brief — Evaluating Angel Remedies as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Angel Remedies has demonstrated a consistent track record in exporting pharmaceutical products, with a total export value of $218,000 USD across 26 shipments in 2022. The company's focus on high-quality generic medicines and adherence to international standards suggest reliability in its supply chain. However, the high concentration of export value in the top five products indicates potential risks associated with market fluctuations affecting these specific products.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Registration: Confirm that the manufacturing facility is registered with the U.S. Food and Drug Administration. Verification can be done through the FDA's official website.

WHO-GMP Certification: Ensure that the manufacturing facility complies with the World Health Organization's Good Manufacturing Practices. Verification can be done through the WHO's official website.

Frequently Asked Questions — Angel Remedies

How many pharmaceutical products does Angel Remedies export from India?

Angel Remedies exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Indomethacin ($187.7K), Paracetamol Caffeine ($29.9K). Total export value is $217.6K.

What is Angel Remedies's total pharmaceutical export value?

Angel Remedies's total pharmaceutical export value is $217.6K, based on 26 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Angel Remedies cover?

Angel Remedies exports across 2 therapeutic categories. The largest are Analgesics & Antipyretics (86.3%, 1 products), Combination Drugs (13.7%, 1 products).

Get Full Angel Remedies Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.